Anti-GD2 Antibody Therapy for GD2-Expressing Tumors

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|2|200-209

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.2, 2010-03, pp. : 200-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The anti-idiotypic antibody 4B5 (mimicking ganglioside GD2) for diagnosis and therapy of cancer

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 2, 2000-02 ,pp. : 255-257

Informa Healthcare

Access to resources Recommend Favorite

Motexafin Gadolinium: Gadolinium (III) Texaphyrin, Gadolinium Texaphyrin, Gd-Tex, GdT2B2, PCI 0120

By Adis International Limited  

Drugs in R&D, Vol. 5, Iss. 1, 2004-01 ,pp. : 52-57

Adis International

Access to resources Recommend Favorite

A Thermo-Sensitive Polymeric Gel Containing a Gadolinium (Gd) Compound Encapsulated into Liposomes Significantly Extended the Retention of the Gd in Tumors

By Le Uyen Minh   Shaker Dalia   Sloat Brian   Cui Zhengrong  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 4, 2008-04 ,pp. : 413-418

Informa Healthcare

Access to resources Recommend Favorite

Imaging of HER-2 Overexpression in Tumors for Guiding Therapy

By  

Current Pharmaceutical Design, Vol. 14, Iss. 28, 2008-10 ,pp. : 2999-3019

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HER2 Cancer Therapy and Cardiotoxicity

By  

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4911-4919

Bentham Science Publishers

Access to resources Recommend Favorite